Back to trial details

Intake questionnaire

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Applying to Northwestern University Feinberg School Of Medicine · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 50 and 85 years old?
2. Have you been diagnosed with Parkinson's Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?